Dan Puckett is Chief Financial Officer of Shockwave Medical, Inc.. Currently has a direct ownership of 21,005 shares of SWAV, which is worth approximately $0. The most recent transaction as insider was on Feb 05, 2024, when has been sold 3,229 shares (Common Stock) at a price of $230.7 per share, resulting in proceeds of $744,930. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21K
0% 3M change
27.53% 12M change
Total Value Held $0

DAN PUCKETT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 05 2024
SELL
Open market or private sale
$744,930 $230.7 p/Share
3,229 Reduced 13.32%
21,005 Common Stock
Feb 05 2024
SELL
Payment of exercise price or tax liability
$791,597 $226.3 p/Share
3,498 Reduced 12.61%
24,234 Common Stock
Feb 01 2024
SELL
Open market or private sale
$783,107 $229.92 p/Share
3,406 Reduced 10.94%
27,732 Common Stock
Jan 17 2024
SELL
Payment of exercise price or tax liability
$450,218 $212.97 p/Share
2,114 Reduced 6.36%
31,138 Common Stock
Jan 12 2024
BUY
Grant, award, or other acquisition
-
5,520 Added 14.24%
33,252 Common Stock
Dec 08 2023
SELL
Open market or private sale
$34,776 $173.88 p/Share
200 Reduced 0.69%
28,784 Common Stock
Nov 02 2023
SELL
Payment of exercise price or tax liability
$43,670 $214.07 p/Share
204 Reduced 0.7%
28,984 Common Stock
Aug 03 2023
SELL
Payment of exercise price or tax liability
$52,521 $250.1 p/Share
210 Reduced 0.71%
29,188 Common Stock
May 11 2023
SELL
Open market or private sale
$598,497 $291.95 p/Share
2,050 Reduced 6.52%
29,398 Common Stock
May 03 2023
SELL
Payment of exercise price or tax liability
$58,959 $280.76 p/Share
210 Reduced 0.66%
31,448 Common Stock
Apr 19 2023
SELL
Open market or private sale
$265,199 $264.67 p/Share
1,002 Reduced 3.07%
31,658 Common Stock
Apr 18 2023
SELL
Payment of exercise price or tax liability
$267,434 $267.97 p/Share
998 Reduced 2.97%
32,660 Common Stock
Mar 20 2023
SELL
Open market or private sale
$220,814 $200.74 p/Share
1,100 Reduced 3.16%
33,658 Common Stock
Mar 20 2023
BUY
Exercise of conversion of derivative security
$18,700 $17.0 p/Share
1,100 Added 3.07%
34,758 Common Stock
Feb 22 2023
SELL
Open market or private sale
$700,243 $191.69 p/Share
3,653 Reduced 9.79%
33,658 Common Stock
Feb 21 2023
SELL
Payment of exercise price or tax liability
$741,932 $192.86 p/Share
3,847 Reduced 9.35%
37,311 Common Stock
Feb 21 2023
SELL
Open market or private sale
$212,124 $192.84 p/Share
1,100 Reduced 2.6%
41,158 Common Stock
Feb 21 2023
BUY
Exercise of conversion of derivative security
$18,700 $17.0 p/Share
1,100 Added 2.54%
42,258 Common Stock
Feb 02 2023
SELL
Open market or private sale
$394,388 $190.25 p/Share
2,073 Reduced 4.8%
41,158 Common Stock
Feb 02 2023
SELL
Payment of exercise price or tax liability
$606,385 $188.26 p/Share
3,221 Reduced 6.93%
43,231 Common Stock
Feb 01 2023
BUY
Grant, award, or other acquisition
-
6,514 Added 12.3%
46,452 Common Stock
Jan 20 2023
SELL
Open market or private sale
$195,195 $177.45 p/Share
1,100 Reduced 2.68%
39,938 Common Stock
Jan 20 2023
BUY
Exercise of conversion of derivative security
$18,700 $17.0 p/Share
1,100 Added 2.61%
41,038 Common Stock
Dec 20 2022
SELL
Open market or private sale
$234,223 $212.93 p/Share
1,100 Reduced 2.68%
39,938 Common Stock
Dec 20 2022
BUY
Exercise of conversion of derivative security
$18,700 $17.0 p/Share
1,100 Added 2.61%
41,038 Common Stock
DP

Dan Puckett

Chief Financial Officer
Santa Clara, CA

Track Institutional and Insider Activities on SWAV

Follow Shockwave Medical, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SWAV shares.

Notify only if

Insider Trading

Get notified when an Shockwave Medical, Inc. insider buys or sells SWAV shares.

Notify only if

News

Receive news related to Shockwave Medical, Inc.

Track Activities on SWAV